Mesoblast Ltd of Australia has raised A$170 million (€136.3 million) in a private placement of its shares with existing and new investors including M&G Investment Management and Capital Research. The monies will fund the company’s cell therapies. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News Regenerative Medicine
